Gastrointestinal Neoplasm Malignant clinical trials

Explore recruiting gastrointestinal neoplasm malignant clinical trials.

Recruiting gastrointestinal neoplasm malignant studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastrointestinal Neoplasm Malignant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(22752) A Phase 2 open-label basket study to evaluate the efficacy and safety of orally administered reversible tyrosine kinase inhibitor BAY 2927088 in participants with metastatic or unresectable solid tumors with HER2-activating mutations

Spain, Denmark, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Gastrointestinal Neoplasm Malignant trials by city

Gastrointestinal Neoplasm Malignant clinical trials

Recruiting gastrointestinal neoplasm malignant studies right now

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

First-in-human Study of 7MW4911 in GI Cancer

BGT007 Cells for the Treatment of Refractory Digestive System Tumors

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Also recruiting in Europe

(22752) A Phase 2 open-label basket study to evaluate the efficacy and safety of orally administered reversible tyrosine kinase inhibitor BAY 2927088 in participants with metastatic or unresectable solid tumors with HER2-activating mutations

Gastrointestinal Neoplasm Malignant trials by city

Other conditions